Kezar Life Sciences | DEF 14A: Definitive information statements
Kezar Life Sciences | ARS: Annual Report to Security Holders
Kezar Life Sciences | DEFA14A: Others
Kezar Life Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Kezar Life Sciences | 424B5: Prospectus
Kezar Life Sciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kezar Life Sciences | 10-K: Annual report
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Capital LLC(2.7%),OrbiMed Advisors LLC(0.0%)
Kezar Life Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Barclays PLC(5.27%),Barclays Bank PLC(5.27%), etc.
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(6.9%),Avidity Partners Management (GP) LLC(6.9%), etc.
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.9%),Aaron Cowen(9.9%), etc.
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prosight Management, LP(4.6%),Prosight Partners, LLC(4.6%), etc.
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.6%)
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.54%)
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(4.0%),Millennium Group Management LLC(4.0%), etc.
Kezar Life Sciences | 3: Initial statement of beneficial ownership of securities-Officer Schiller Mark C.
Kezar Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Belsky Marc
Kezar Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Mordwinkin Nicholas Michael
Kezar Life Sciences | 8-K: Current report
No Data